Publisher Summary This chapter discusses the immunotherapeutic procedure known as
extracorporeal photopheresis (ECP). Extracorporeal Photopheresis involves the ex vivo …

Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy based upon pheresis of light‐sensitive cells. Whole blood is removed from patients …

Extracorporeal photopheresis (ECP or photopheresis) is an advanced therapeutic apheresis
procedure in which blood is separated into its various components and the isolated buffy …

Extracorporeal phototherapy (ECP) is a therapeutic approach based on the biological effect
of psoralen 8-methoxypsoralen (8-MOP) and ultraviolet light A (UVA) on mononuclear cells …

Extracorporeal photopheresis (ECP) combines the collection of white blood cells treated
with 8-methoxypsoralen (8-MOP), photoactivation with ultraviolet A, and reinfusion of the …

Extracorporeal photopheresis involves the exposure of the patient's mononuclear cells to 8-
methoxypsoralen and ultraviolet A light to induce apoptosis of the T cells. Currently …

Extracorporeal photopheresis (ECP) is a cell-based immunotherapy that involves the
reinfusion of autologous leukocytes after exposure to psoralen and UVA. The treatment has …

Extracorporeal photopheresis (ECP) is a combination of leukapheresis and photodynamic
therapy in which blood is treated with photoactivable drugs which are then activated with …

During the treatment of extracorporeal photopheresis (ECP), white blood cells are collected
by apheresis and exposed to ultraviolet A after incubation with 8-methoxypsoralen. Although …

Extracorporeal photopheresis (ECP) has had a major impact in the treatment of various
conditions in the past 25 years. Although it was initially developed for the treatment of …